Warning
Mae'r hysbyseb swydd hon wedi dod i ben ac mae'r ceisiadau wedi cau.
12852 - Post Doctoral Research Fellow
Dyddiad hysbysebu: | 01 Awst 2025 |
---|---|
Cyflog: | £41,064 i £48,822 bob blwyddyn |
Oriau: | Llawn Amser |
Dyddiad cau: | 14 Awst 2025 |
Lleoliad: | Edinburgh |
Gweithio o bell: | Hybrid - gweithio o bell hyd at 3 ddiwrnod yr wythnos |
Cwmni: | University of Edinburgh |
Math o swydd: | Cytundeb |
Cyfeirnod swydd: | 12852 |
Crynodeb
Grade UE07: £41,064 - £48,822 per annum
CMVM / Deanery of Clinical Sciences / Centre for Cardiovascular Sciences
Full time: 35 hours per week
Fixed-Term: until 28/02/2027 (possibility of extension until 30/06/27)
The Opportunity:
We are seeking applications for a PDRA to join the dynamic research group of Dr Denby working on an exciting translational MRC funded study in which we are targeting scar-associated monocyte-derived macrophages (SAMac) to reduce fibrosis and the mechanisms associated with this. This project is in collaboration with the Ramachandran and Walmsley research labs of the Institute of Regeneration and Repair (IRR). This cutting-edge project involves sc/sn RNA sequencing and analysis of human and mouse kidney and liver samples, spatial transcriptomics, multiplex tissue staining, informative transgenic animal studies and metabolomics. The Denby lab is located in the Institute of Neuroscience and Cardiovascular Research (INCR) and is part of Edinburgh Kidney (https://edinburghkidney.co.uk/). The studies to be undertaken will be conducted between INCR and the IRR.
This post is full-time (35 hours per week); however, we are open to considering part-time or flexible working patterns.
Your skills and attributes for success:
The candidate must have a PhD (submitted or obtained) in immunology / biological sciences or related.
Strong theoretical knowledge of the mechanisms driving fibrosis.
Theoretical knowledge / experience of the application of flow cytometry and cell sorting.
Experience in metabolomics and/or immunometabolism
Experience in bioinformatic analysis of sc/sn RNA sequencing data
Practical knowledge of cell culture and immunostaining.
Knowledge of pre-clinical models of fibrosis.
CMVM / Deanery of Clinical Sciences / Centre for Cardiovascular Sciences
Full time: 35 hours per week
Fixed-Term: until 28/02/2027 (possibility of extension until 30/06/27)
The Opportunity:
We are seeking applications for a PDRA to join the dynamic research group of Dr Denby working on an exciting translational MRC funded study in which we are targeting scar-associated monocyte-derived macrophages (SAMac) to reduce fibrosis and the mechanisms associated with this. This project is in collaboration with the Ramachandran and Walmsley research labs of the Institute of Regeneration and Repair (IRR). This cutting-edge project involves sc/sn RNA sequencing and analysis of human and mouse kidney and liver samples, spatial transcriptomics, multiplex tissue staining, informative transgenic animal studies and metabolomics. The Denby lab is located in the Institute of Neuroscience and Cardiovascular Research (INCR) and is part of Edinburgh Kidney (https://edinburghkidney.co.uk/). The studies to be undertaken will be conducted between INCR and the IRR.
This post is full-time (35 hours per week); however, we are open to considering part-time or flexible working patterns.
Your skills and attributes for success:
The candidate must have a PhD (submitted or obtained) in immunology / biological sciences or related.
Strong theoretical knowledge of the mechanisms driving fibrosis.
Theoretical knowledge / experience of the application of flow cytometry and cell sorting.
Experience in metabolomics and/or immunometabolism
Experience in bioinformatic analysis of sc/sn RNA sequencing data
Practical knowledge of cell culture and immunostaining.
Knowledge of pre-clinical models of fibrosis.